AUTL
Autolus Therapeutics
AUTL
AUTL
39 hedge funds and large institutions have $546M invested in Autolus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
39
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$283M | |
| 2 | +$23.5M | |
| 3 | +$14.7M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.63M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$2.03M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$8.32M | |
| 3 | -$6.12M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$4.02M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.48M |